TAVR in Patients with Moderate Aortic Stenosis with At-Risk Features
Year: 2026
Type: article
Study designs: Randomized Controlled Trial, Clinical Trial
Source: New England Journal of Medicine
Authors: Philippe Généreux, Raj R. Makkar, Philippe Pibarot, Jeroen J. Bax, Brian R. Lindman, Kamran Muhammad, J. Bradley Oldemeyer, Mark Pirwitz, Colin M. Barker, Vinod H. Thourani, Pradeep K. Yadav, Roberto Rodriguez, Justin Strote, Rahul Sakhuja, Ramzi Khalil, Rahul Sharma, Adnan Chhatriwalla, Jacob M. Mishell, Biswajit Kar, Sameer Gafoor, Joseph Walsh, Daniel Spoon, Andrew Frutkin, Andrei Pop, Nicolas M. Van Mieghem, Ruby Satpathy, Kenji Ando, Joseph Montarello, John Webb, Sreekanth Vemulapalli, David J. Cohen, Aakriti Gupta, Brandon Park, Heather Prince, Philipp Blanke, Michael Mack, Martin B. Leon
Institutions: Morristown Medical Center, Atlantic Health System, Cedars-Sinai Medical Center, Institut universitaire de cardiologie et de pneumologie de Québec, Leiden University Medical Center, Vanderbilt University Medical Center, Oklahoma Heart Institute, University of Colorado Health, Ascension, Piedmont Atlanta Hospital, Lankenau Medical Center, Harvard University, Massachusetts General Hospital, Mass General Brigham, Allegheny-Singer Research Institute, Stanford Medicine, Saint Luke's Hospital, Kaiser Permanente San Francisco Medical Center, The University of Texas Health Science Center at Houston, Saint Alphonsus Health System, St. Patrick Hospital, Eisenhower Medical Center, Alexian Brothers Medical Center, Ziekenhuis Oost-Limburg, Erasmus University Rotterdam, Baptist Medical Center Jacksonville, Kokura Memorial Hospital, Royal Adelaide Hospital, University of British Columbia, St. Paul's Hospital, Duke University, Duke Medical Center, St. Francis Hospital, Cardiovascular Research Foundation, Edwards Lifesciences (United States), Heart Hospital Baylor Plano, Columbia University Irving Medical Center
Language: English
Subfield: Cardiology and Cardiovascular Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
Funder: Edwards Lifesciences
OpenAlex ID: W7225127387